Featuring an abstract from ISMPP’s 16th Annual Meeting, Springer Nature’s commitment to DORA, a reflection on how COVID-19 is impacting clinical research, interpretations of the meaning of open science, preprint policy updates from PLOS, a public appeal to the EMA and what’s standing in the way of open access. Coco et al. 2020: surveying open … Continue reading Weekly digest: what’s happening in open science?
Blog
Guest post: The open road
For many stakeholders within the healthcare industry, the world of open research is an exciting yet occasionally confusing one. At the start of this year, key industry players from across the pharma industry met in Oxford for a roundtable discussion hosted by Wiley on ‘How the pharma–publisher relationship should evolve in the new world of … Continue reading Guest post: The open road
Weekly digest: what’s happening in open science?
Featuring eLife’s new peer review service, quality control measures for preprint servers, STM’s Innovation Day keynote on ethics and data science, a task force to tackle image duplication, a call for improved open access infrastructure, ASBMB’s commitment to open access and a response from the British Library. A peer review service for preprints via eLife … Continue reading Weekly digest: what’s happening in open science?
Weekly digest: what’s happening in open science?
Featuring top tips for maintaining accuracy and integrity in scientific reporting, the need to share algorithmic inputs of scientific models, efforts to streamline and improve time-to-publication metrics and peer review processes, Evidence Aid’s work on coronavirus research summaries and CRUK’s commitment to Plan S. Maintaining journalistic integrity in the era of preprint servers via Columbia … Continue reading Weekly digest: what’s happening in open science?
Weekly digest: what’s happening in open science?
Featuring new endorsements of the Open Pharma position statement on open access, the ISMPP U webinar on COVID-19 and publication planning, an effort to make ClinicalTrials.gov more user-friendly, the importance of lay summaries, a coalition of publishers, the COVID-19 Antiviral Candidate Compounds Dataset, an investigation into the diversity of preprint servers and an analysis into … Continue reading Weekly digest: what’s happening in open science?
Weekly digest: what’s happening in open science?
Featuring the driving forces of open science, the European COVID-19 Data Portal, the launch of IndiaRxiv, a survey investigating opinions on co-reviewing, a study on open science principles, how COVID-19 is reshaping science and a breakdown of the Creative Commons licences. A tale of two ‘buts’ via WONKHE Elizabeth Gadd, Research Policy Manager at Loughborough … Continue reading Weekly digest: what’s happening in open science?
Weekly digest: what’s happening in open science?
Featuring new guidance on transformative agreements and hybrid journals from cOAlition S, Springer Nature’s commitment to Plan S, results from ISMPP’s survey on author order, consultations with UNESCO on open science, the theme of this year’s Peer Review Week, Registered Reports and a re-examination of what disciplines are considered to be relevant to COVID-19. Approaches … Continue reading Weekly digest: what’s happening in open science?
Weekly digest: what’s happening in open science?
Featuring an update to TranspariMED’s COVID-19 database, the Virus Outbreak Data Network in Africa, a review of research participants’ opinions on data sharing, the results from the State of Open Data 2019 annual survey, the Open Access Directory and an open letter to the Prime Minister of the UK. UPDATE: the database of databases via … Continue reading Weekly digest: what’s happening in open science?
Weekly digest: what’s happening in open science?
Featuring our 100th individual endorsement, the balance between open and proprietary science, the reality of the open access vision, the COVID-19 Health Literacy Project, a meta-database of COVID-19 clinical trials, a new journal metric and tips for making the most of article metrics. Our 100th individual endorsement via Open Pharma We at Open Pharma are … Continue reading Weekly digest: what’s happening in open science?
Weekly digest: what’s happening in open science?
Featuring the COVID Symptom Tracker, a comparison between the COVID-19 and 2002–2003 SARS outbreaks, new ISMPP authorship guidance, a collaboration of international scientific advisers calling for open science, an opportunity for the NIH, viral genome sequencing efforts, the digital transformation of data sharing and future conferences. Novel coronavirus (COVID-19) symptom tracking: crowdsourced data collection via … Continue reading Weekly digest: what’s happening in open science?